The Aspirin Dilemma in an Older Women with Asthma and Coronary Artery Disease : A Case Report of suspected Aspirin Exacerbated Respiratory Disease

Introduction: Aspirin-exacerbated respiratory disease (AERD, also called aspirin-induced asthma or Samter's triad) is an asthma phenotype in which aspirin and other COX-1 inhibitors can trigger bronchospasm, usually alongside chronic rhinosinusitis with nasal polyps. It creates a real prescribing problem when the patient also has coronary artery disease, because the drug that protects the heart may be the one that provokes the airway. Choosing a safe antiplatelet drug, while keeping the asthma regimen safe too, calls for close cooperation between the treating team and the clinical pharmacist. Main symptoms and clinical findings: A 71-year-old woman with long-standing asthma, a previous episode of pulmonary infiltrates with eosinophilia (PIE), recurrent rhinitis and coronary artery disease came in with two to three days of worsening wheeze, chest tightness and increased sputum. She had bilateral wheeze but stable vital signs, with an oxygen saturation of 98% on room air. High-sensitivity troponin I was normal (1.9 pg/mL), and her renal and liver function were normal. Diagnoses, interventions and outcomes: The working diagnosis was an acute exacerbation of asthma with possible AERD. She was treated with nebulised levosalbutamol–ipratropium, formoterol–budesonide, tiotropium, intravenous hydrocortisone, etofylline/theophylline, montelukast–levocetirizine and antibiotics. Sinus CT showed no polyps and no aspirin reaction was documented, so the AERD label stayed presumptive. After cardiology review, aspirin was stopped on Day 4, while clopidogrel and rosuvastatin were continued. Her wheeze, breathlessness and sputum improved, and she went home on Day 6. Conclusion: When an older patient with asthma and coronary disease may have AERD, the aspirin question is a medicines problem as much as a diagnostic one. Here, a presumptive label made without nasal polyps or a documented aspirin reaction led to aspirin being stopped and clopidogrel continued. The case argues for a structured aspirin and NSAID history at admission, so that antiplatelet decisions rest on a recorded reaction and not on suspicion.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24270997
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Aspirin Dilemma in an Older Women with Asthma and Coronary Artery Disease : A Case Report of suspected Aspirin Exacerbated Respiratory Disease

Mirdula Mary E, Mourishnawin R K, Marin Aravindh A D, Dr Ramanaprasanth G
Zenodo (CERN European Organization for Nuclear Research)
Asthma and respiratory diseases
article

The Aspirin Dilemma in an Older Women with Asthma and Coronary Artery Disease : A Case Report of suspected Aspirin Exacerbated Respiratory Disease

Mirdula Mary E, Mourishnawin R K, Marin Aravindh A D, Dr Ramanaprasanth G
article en

Abstract

Introduction: Aspirin-exacerbated respiratory disease (AERD, also called aspirin-induced asthma or Samter's triad) is an asthma phenotype in which aspirin and other COX-1 inhibitors can trigger bronchospasm, usually alongside chronic rhinosinusitis with nasal polyps. It creates a real prescribing problem when the patient also has coronary artery disease, because the drug that protects the heart may be the one that provokes the airway. Choosing a safe antiplatelet drug, while keeping the asthma regimen safe too, calls for close cooperation between the treating team and the clinical pharmacist. Main symptoms and clinical findings: A 71-year-old woman with long-standing asthma, a previous episode of pulmonary infiltrates with eosinophilia (PIE), recurrent rhinitis and coronary artery disease came in with two to three days of worsening wheeze, chest tightness and increased sputum. She had bilateral wheeze but stable vital signs, with an oxygen saturation of 98% on room air. High-sensitivity troponin I was normal (1.9 pg/mL), and her renal and liver function were normal. Diagnoses, interventions and outcomes: The working diagnosis was an acute exacerbation of asthma with possible AERD. She was treated with nebulised levosalbutamol–ipratropium, formoterol–budesonide, tiotropium, intravenous hydrocortisone, etofylline/theophylline, montelukast–levocetirizine and antibiotics. Sinus CT showed no polyps and no aspirin reaction was documented, so the AERD label stayed presumptive. After cardiology review, aspirin was stopped on Day 4, while clopidogrel and rosuvastatin were continued. Her wheeze, breathlessness and sputum improved, and she went home on Day 6. Conclusion: When an older patient with asthma and coronary disease may have AERD, the aspirin question is a medicines problem as much as a diagnostic one. Here, a presumptive label made without nasal polyps or a documented aspirin reaction led to aspirin being stopped and clopidogrel continued. The case argues for a structured aspirin and NSAID history at admission, so that antiplatelet decisions rest on a recorded reaction and not on suspicion.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon